Guide to use of ferumoxytol for hepatic vascular assessment as part of dual contrast MRI
- 21 August 2023
- journal article
- research article
- Published by Springer Nature in Pediatric Radiology
- Vol. 53 (11) , 2180-2187
Abstract
Magnetic resonance imaging (MRI) assessment of hepatic vasculature can be challenging in the setting of liver disease and liver lesions. The widely used hepatobiliary contrast agent gadoxetate is an extracellular contrast agent that provides excellent soft tissue characterization but has limitations as a vascular contrast agent. Ferumoxytol is an iron oxide nanoparticle with superparamagnetic properties that can be used as blood pool contrast agent to provide dedicated vascular assessment. We provide a detailed protocol for evaluation of pediatric liver vasculature using ferumoxytol, after imaging of the parenchyma with gadoxetate. We provide multiple examples and discuss practical considerations when incorporating ferumoxytol into practice.Keywords
This publication has 21 references indexed in Scilit:
- Relaxivity of Ferumoxytol at 1.5 T and 3.0 TInvestigative Radiology, 2018
- 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)Pediatric Radiology, 2018
- Current and potential imaging applications of ferumoxytol for magnetic resonance imagingKidney International, 2017
- Intravenous Ferumoxytol in Pediatric Patients With Iron Deficiency AnemiaAnnals of Pharmacotherapy, 2017
- Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR‐angiography at 3.0 tesla: Effects of contrast bolus length and flip angleJournal of Magnetic Resonance Imaging, 2016
- MRI Assessment of Hepatic Iron Clearance Rates After USPIO Administration in Healthy AdultsInvestigative Radiology, 2012
- Double-Dose Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients With Chronic Liver DiseaseInvestigative Radiology, 2011
- Gadoxetate Disodium–Enhanced Hepatic MRI: Dose-Dependent Contrast Dynamics of Hepatic Parenchyma and Portal VeinAmerican Journal of Roentgenology, 2011
- Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field StrengthsInvestigative Radiology, 2005
- Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.Radiology, 1996